Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
Paris, France, and Houston, Texas, September 12, 2024.
As part of its effort to develop innovative treatments for people living...
Zur Pressemeldung auf www.sanofi.com